Skip to main content
Abhishek Mangaonkar, MD, Hematology, Rochester, MN

Abhishek Mangaonkar MD

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias


Assistant Professor and Senior Associate Consultant, Mayo Clinic

Join to View Full Profile
  • 200 1st Street SWRochester, MN 55905

Dr. Mangaonkar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • I am a hematology/oncology fellow at the Mayo Clinic.

Education & Training

  • Mayo Clinic College of Medicine and Science (Phoenix)
    Mayo Clinic College of Medicine and Science (Phoenix)Fellowship, Hematology and Medical Oncology, 2016 - 2019
  • Medical College of Georgia
    Medical College of GeorgiaResidency, Internal Medicine, 2013 - 2016
  • Grant Medical College
    Grant Medical CollegeClass of 2012

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2016 - 2025
  • MA State Medical License
    MA State Medical License 2020 - 2020
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • Hematology
    National Board of Physicians and Surgeons Hematology
  • Internal Medicine
    National Board of Physicians and Surgeons Internal Medicine
  • Medical Oncology
    National Board of Physicians and Surgeons Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prognostic Impact of ASXL1 Mutations in Patients with Myelodysplastic Syndromes and Multilineage Dysplasia with or Without Ring Sideroblasts  
    Abhishek A Mangaonkar, Kebede H Begna, Leukemia Research

Authored Content

  • Prognostic Impact of ASXL1 Mutations in Patients with Myelodysplastic Syndromes and Multilineage Dysplasia with or Without Ring SideroblastsJuly 2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: